# OnCo record paper-schirripa-kras-g12c-metastatic-colorectal-clin-colorectal-cancer-2020 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-schirripa-kras-g12c-metastatic-colorectal-clin-colorectal-cancer-2020/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-schirripa-kras-g12c-metastatic-colorectal-clin-colorectal-cancer-2020" ;
  schema:name "KRAS G12C metastatic colorectal cancer: specific features of a new emerging target population"@en ;
  schema:description "As the first KRAS G12C drugs arrived, this study described the patients they would treat: about one in six KRAS-mutant bowel cancers, more often men, more often with lung and liver spread, and with shorter survival than other KRAS mutations."@en ;
  schema:url <https://onco.cc/key-papers/paper-schirripa-kras-g12c-metastatic-colorectal-clin-colorectal-cancer-2020/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/j.clcc.2020.04.009>, <https://pubmed.ncbi.nlm.nih.gov/32605718/> ;
  schema:sameAs <https://doi.org/10.1016/j.clcc.2020.04.009> ;
  schema:datePublished "2020"^^xsd:gYear ;
  schema:author "Schirripa M, Nappo F, Cremolini C, et al." ;
  onco:related <https://onco.cc/biomarkers/kras-g12c/> ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:technologies <https://onco.cc/technologies/kras-inhibitors/> ;
  onco:targets <https://onco.cc/targets/kras/> ;
  onco:pathways <https://onco.cc/pathways/ras-mapk/> ;
  onco:journals <https://onco.cc/journals/clinical-colorectal-cancer/> .